A liquid biopsy blood test may improve children's survival of cancer in Africa

medicalxpress - In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es Salaam, Tanzania have shown that a minimally invasive liquid biopsy test can diagnose Burkitt l…

AI Summary: A blood‑based liquid biopsy for EBV‑positive Burkitt’s lymphoma shows promise for earlier, less invasive diagnosis in endemic regions, potentially improving pediatric survival where tissue biopsies are scarce. Early data indicate actionable sensitivity and feasibility for low‑resource settings, offering a scalable path to faster treatment.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

Grail’s Galleri blood test misses UK study goal; investor jitters / 3 months

Ultra‑sensitive ctDNA blood test could personalize breast cancer care for older women / 2 months

Nature study links adult thymus to longevity and cancer therapy / 2 months

Grail names new CEO as Bob Ragusa retires / 2 months

Major study finds GRAIL multi‑cancer blood test did not detect cancers earlier / 3 months

UCLA unveils low-cost blood test to detect multiple cancers from one sample / 7 wks

Previously unknown virus found inside gut bacteria linked to colorectal cancer / 3 months